Meta-analysis of 13 RCTs (528 patients) with obstructive sleep apnoea: atomoxetine combination therapy lowered AHI versus placebo (MD −5.83 events/h) and improved oxygenation, but raised total adverse events (RR 1.65), including dry mouth and difficulty urinating.
Meta-analysisn = 528
Zhao et al. Efficacy and safety of atomoxetine combination therapy for obstructive sleep apnea: A meta-analysis of randomized placebo-controlled trials